Cost-effectiveness of vildagliptin for people with type 2 diabetes mellitus in Brazil; findings and implications
{{output}}
Vildagliptin is an inhibitor of the enzyme dipeptidyl peptidase 4, indicated for the treatment of type 2 diabetes mellitus, combined or not with metformin. This study aims to evaluate the cost-effectiveness of vildagliptin in the Brazilian context. Areas cover... ...
